FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161019968> ?p ?o ?g. }

• W2161019968 endingPage "145" @default.
• W2161019968 startingPage "136" @default.
• W2161019968 abstract "Tumour-derived chaperone-rich cell lysate (CRCL), which is made up of numerous heat shock proteins, has been used successfully to generate tumour-specific T cell responses and protective immunity against a wide range of murine tumours. In this study, we have investigated the potency of human ovarian cancer-derived CRCL to activate dendritic cells (DC) and to generate tumour-specific T cells in vitro. CRCL was generated from primary ovarian cancers and SKOV3-A2, a HER2/neu, Wilm's tumour gene 1 (WT1) and human leucocyte antigen (HLA)-A2 positive human ovarian tumour cell line. Peripheral blood mononuclear cells from both HLA-A2(+) healthy donors and HLA-A2(+) ovarian cancer patients were stimulated weekly with autologous DC loaded with ovarian tumour-derived CRCL. After four to six stimulations in vitro, specific cytokine secretion and cytotoxicity were measured. CRCL promoted interleukin (IL)-12 secretion and enhanced the immunostimulatory capacity of DC. T cells from healthy controls and from ovarian cancer patients secreted higher amounts of interferon-gamma following in vitro restimulation with ovarian cancer-derived CRCL than with HER2/neu or WT1 peptide-pulsed DC. We were also able to generate cytotoxic T lymphocyte activity against cancer-specific antigens such as HER2/neu and WT1 from all healthy donors, but from only one of the four ovarian cancer patients with bulky disease. These preliminary results substantiate further the concept that CRCL may prove to be a potent adjuvant for women suffering from ovarian cancer and that this personalized vaccine may be a promising approach for active immunotherapy." @default.
• W2161019968 created "2016-06-24" @default.
• W2161019968 creator A5000229246 @default.
• W2161019968 creator A5010187620 @default.
• W2161019968 creator A5026358779 @default.
• W2161019968 creator A5026652632 @default.
• W2161019968 creator A5029494360 @default.
• W2161019968 creator A5035397993 @default.
• W2161019968 creator A5036696622 @default.
• W2161019968 creator A5041469650 @default.
• W2161019968 creator A5046295261 @default.
• W2161019968 date "2007-01-26" @default.
• W2161019968 modified "2023-09-23" @default.
• W2161019968 title "Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses <i>in vitro</i>" @default.
• W2161019968 cites W136092066 @default.
• W2161019968 cites W1517416547 @default.
• W2161019968 cites W1530844897 @default.
• W2161019968 cites W1558109280 @default.
• W2161019968 cites W1561591381 @default.
• W2161019968 cites W156241630 @default.
• W2161019968 cites W1569070916 @default.
• W2161019968 cites W1963592300 @default.
• W2161019968 cites W1976342692 @default.
• W2161019968 cites W1991830271 @default.
• W2161019968 cites W1997989415 @default.
• W2161019968 cites W2001015172 @default.
• W2161019968 cites W2013707917 @default.
• W2161019968 cites W2022369366 @default.
• W2161019968 cites W2035862592 @default.
• W2161019968 cites W2046972425 @default.
• W2161019968 cites W2051940153 @default.
• W2161019968 cites W2053925603 @default.
• W2161019968 cites W2061561495 @default.
• W2161019968 cites W2064773757 @default.
• W2161019968 cites W2077147164 @default.
• W2161019968 cites W2077273880 @default.
• W2161019968 cites W2079684065 @default.
• W2161019968 cites W2080335579 @default.
• W2161019968 cites W2083155294 @default.
• W2161019968 cites W2099735866 @default.
• W2161019968 cites W2104373565 @default.
• W2161019968 cites W2123311867 @default.
• W2161019968 cites W2124376809 @default.
• W2161019968 cites W2131023026 @default.
• W2161019968 cites W2145136557 @default.
• W2161019968 cites W2147618576 @default.
• W2161019968 cites W2155906523 @default.
• W2161019968 cites W2161669288 @default.
• W2161019968 cites W2165222076 @default.
• W2161019968 cites W2171803299 @default.
• W2161019968 cites W2174651809 @default.
• W2161019968 cites W2693788 @default.
• W2161019968 doi "https://doi.org/10.1111/j.1365-2249.2007.03323.x" @default.
• W2161019968 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1868858" @default.
• W2161019968 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17349014" @default.
• W2161019968 hasPublicationYear "2007" @default.
• W2161019968 type Work @default.
• W2161019968 sameAs 2161019968 @default.
• W2161019968 citedByCount "24" @default.
• W2161019968 countsByYear W21610199682012 @default.
• W2161019968 countsByYear W21610199682013 @default.
• W2161019968 countsByYear W21610199682015 @default.
• W2161019968 countsByYear W21610199682016 @default.
• W2161019968 countsByYear W21610199682021 @default.
• W2161019968 crossrefType "journal-article" @default.
• W2161019968 hasAuthorship W2161019968A5000229246 @default.
• W2161019968 hasAuthorship W2161019968A5010187620 @default.
• W2161019968 hasAuthorship W2161019968A5026358779 @default.
• W2161019968 hasAuthorship W2161019968A5026652632 @default.
• W2161019968 hasAuthorship W2161019968A5029494360 @default.
• W2161019968 hasAuthorship W2161019968A5035397993 @default.
• W2161019968 hasAuthorship W2161019968A5036696622 @default.
• W2161019968 hasAuthorship W2161019968A5041469650 @default.
• W2161019968 hasAuthorship W2161019968A5046295261 @default.
• W2161019968 hasBestOaLocation W21610199682 @default.
• W2161019968 hasConcept C121608353 @default.
• W2161019968 hasConcept C137061746 @default.
• W2161019968 hasConcept C147483822 @default.
• W2161019968 hasConcept C154317977 @default.
• W2161019968 hasConcept C202751555 @default.
• W2161019968 hasConcept C203014093 @default.
• W2161019968 hasConcept C2776090121 @default.
• W2161019968 hasConcept C2780084626 @default.
• W2161019968 hasConcept C2780427987 @default.
• W2161019968 hasConcept C502942594 @default.
• W2161019968 hasConcept C54355233 @default.
• W2161019968 hasConcept C55493867 @default.
• W2161019968 hasConcept C86803240 @default.
• W2161019968 hasConcept C8891405 @default.
• W2161019968 hasConceptScore W2161019968C121608353 @default.
• W2161019968 hasConceptScore W2161019968C137061746 @default.
• W2161019968 hasConceptScore W2161019968C147483822 @default.
• W2161019968 hasConceptScore W2161019968C154317977 @default.
• W2161019968 hasConceptScore W2161019968C202751555 @default.
• W2161019968 hasConceptScore W2161019968C203014093 @default.
• W2161019968 hasConceptScore W2161019968C2776090121 @default.
• W2161019968 hasConceptScore W2161019968C2780084626 @default.
• W2161019968 hasConceptScore W2161019968C2780427987 @default.

• next